The combined effects of STAT5 activation and PAX5 deficiency is well in line with the observations that activating mutations in in the Il7 or TSLP signaling pathways are frequently observed in human B-ALL [35, 36]. This evidence concerns the gene PAX5 and precursor B-cell acute lymphoblastic leukemia.